v3.23.3
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:
Cash and cash equivalents $ 138,621 $ 153,191
Accounts receivable, net 117,449 127,312
Inventory, net 68,960 74,060
Other current assets and prepaid expenses 32,209 39,962
Total current assets 357,239 394,525
Property, plant and equipment, net 78,170 82,879
Intangible assets, net 758,414 823,520
In-process research and development 195,000 195,000
Goodwill 594,457 595,851
Investments 19,377 28,080
Operating lease right-of-use assets 44,691 38,725
Other assets 9,333 8,679
Total assets 2,056,680 2,167,259
Current liabilities:
Accounts payable 66,801 66,993
Accrued expenses 92,368 98,269
Current maturities of operating leases 11,267 11,628
Current portion of convertible notes 0 3,050
Current portion of lines of credit and notes payable 30,118 33,540
Total current liabilities 200,554 213,480
Operating lease liabilities 34,649 27,963
Long term portion of convertible notes 213,285 210,371
Deferred tax liabilities 138,007 126,426
Other long-term liabilities, principally contract liabilities, contingent consideration and lines of credit 25,617 27,371
Total long-term liabilities 411,558 392,131
Total liabilities 612,112 605,611
Equity:
Common Stock - $0.01 par value, 1,000,000,000 shares authorized; 781,711,885 and 781,306,164 shares issued at September 30, 2023 and December 31, 2022, respectively 7,817 7,813
Treasury Stock - 8,655,082 shares at September 30, 2023 and December 31, 2022, respectively (1,791) (1,791)
Additional paid-in capital 3,430,340 3,421,872
Accumulated other comprehensive loss (46,495) (43,323)
Accumulated deficit (1,945,303) (1,822,923)
Total shareholders’ equity 1,444,568 1,561,648
Total liabilities and equity $ 2,056,680 $ 2,167,259

Source